Obsah
Editorial .................................................................................................... 33
Přehledné články
Vitamin D a VDR aktivátory – novinky v prevenci
a léčbě sekundární hyperparathyreózy
Sylvie Dusilová Sulková, Vladimír Palička .................................................. 38
Vitamin D – imunomodulační hormon
Jiřina Bartůňková ....................................................................................... 46
Preimplantační genetické testování u pacientů s ADPKD
Pavel Navrátil, Pavel Navrátil, Jan Diblík,
Kateřina Sobolová, Veronika Sabolová,
Jitka Štekrová, Jiří Doležal ......................................................................... 52
Rozhovor
MUDr. Jana Lachmanová ........................................................................... 59
Předplatné ................................................................................................ 63
Pokyny autorům ....................................................................................... 64
CONTENTS
Editorial .................................................................................................... 33
Contents ................................................................................................... 35
Reviews
Vitamin D and VDR activators – new developments
in the prevention and treatment of secondary hyperparathyroidism
Sylvie Dusilová Sulková, Vladimír Palička ................................................... 38
Vitamin D – an immunomodulatory hormone
Jiřina Bartůňková ........................................................................................ 46
Preimplantation genetic testing in patients with ADPKD
Pavel Navrátil, Pavel Navrátil, Jan Diblík, Kateřina Sobolová,
Veronika Sabolová, Jitka Štekrová, Jiří Doležal ........................................... 52
Interview
MUDr. Jana Lachmanová ............................................................................ 59
Subscription ............................................................................................... 63
Instruction for authors ............................................................................... 64



